PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...
More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The Home Fix It Show With Dave Baker, on-demand. While weekly archives will still appear on TheHomeFixitPage.com, if you just can't wait, get it here. Home-Fix-It radio host Dave Baker offers seasonal ...
Brent Lang is the Executive Editor of Variety, covering the major Hollywood studios, as well as their corporate parents. He joined Variety in 2014. He was previously a senior reporter at TheWrap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results